1. Home
  2. USA vs GRDN Comparison

USA vs GRDN Comparison

Compare USA & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$5.63

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Guardian Pharmacy Services Inc.

GRDN

Guardian Pharmacy Services Inc.

HOLD

Current Price

$32.42

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
USA
GRDN
Founded
N/A
2004
Country
United States
United States
Employees
N/A
3400
Industry
Finance Companies
Retail-Drug Stores and Proprietary Stores
Sector
Finance
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
USA
GRDN
Price
$5.63
$32.42
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$37.33
AVG Volume (30 Days)
1.1M
200.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.13
Revenue Next Year
N/A
$9.97
P/E Ratio
N/A
$117.77
Revenue Growth
N/A
N/A
52 Week Low
$5.64
$19.17
52 Week High
$6.96
$37.43

Technical Indicators

Market Signals
Indicator
USA
GRDN
Relative Strength Index (RSI) 24.52 47.76
Support Level N/A $31.82
Resistance Level $6.66 $34.98
Average True Range (ATR) 0.07 1.75
MACD -0.03 -0.17
Stochastic Oscillator 1.27 26.98

Price Performance

Historical Comparison
USA
GRDN

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

About GRDN Guardian Pharmacy Services Inc.

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

Share on Social Networks: